[Immunosuppressive therapy and post-operative wound healing]

Area of Science:

• Immunology
• Surgical Medicine
• Pharmacology

Background:

• Immunosuppressive medications are vital for managing autoimmune diseases and preventing organ transplant rejection.
• Patients undergoing immunosuppressive therapy present unique challenges in surgical settings, potentially increasing risks.
• Effective perioperative care protocols are essential to mitigate adverse outcomes in this patient population.

Purpose of the Study:

• To review existing literature on the impact of immunosuppressive treatment on post-operative infections.
• To examine the relationship between immunosuppressive therapy and wound-healing complications after surgery.
• To identify challenges and potential strategies for perioperative management of immunosuppressed patients.

Main Methods:

• Systematic literature search of relevant databases (e.g., PubMed, Scopus).
• Inclusion of studies focusing on post-operative outcomes in patients receiving immunosuppressive agents.
• Analysis of data concerning infection rates and wound healing parameters.

Main Results:

• Immunosuppressive treatment is associated with a statistically significant increase in the incidence of post-operative infections.
• Delayed wound healing and wound-healing complications are more prevalent in patients on immunosuppressive therapy.
• Variability in immunosuppressive drug classes and surgical procedures complicates standardized management.

Conclusions:

• Immunosuppressed patients require careful perioperative management to minimize infection and wound healing risks.
• Further research is needed to establish evidence-based guidelines for managing immunosuppressive therapy around surgical procedures.
• Multidisciplinary collaboration between surgical teams and immunologists is recommended for optimal patient care.